Overexpression of the 32-kilodalton dopamine and cyclic adenosine 3′,5′-monophosphate-regulated phosphoprotein in common adenocarcinomas

Cancer

Volumn 98, Issue 7, 2003, Pages 1547-1551

  Beckler, Andy ^a   Moskaluk, Christopher A ^a   Zaika, Alexander ^a   Hampton, Garret M ^b   Powell, Steven M ^a   Frierson Jr , Henry F ^a   El Rifai, Wa'el ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

Author keywords

32 kilodalton dopamine and cyclic adenosine 3 ,5 monophosphate regulated phosphoprotein; Adenocarcinoma; Immunohistochemistry; Reverse transcriptase polymerase chain reaction

Indexed keywords

CYCLIC AMP; DARPP 32 PROTEIN; DOPAMINE; GENE PRODUCT; PHOSPHOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST ADENOCARCINOMA; CARCINOGENESIS; COLON ADENOCARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CULTURE TECHNIQUES; DOPAMINE; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASMS; NERVE TISSUE PROTEINS; PHOSPHOPROTEINS; PROSTATIC NEOPLASMS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS;

EID: 0141675066     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11654     Document Type: Article

References (11)

1. Greengard P. The neurobiology of slow synaptic transmission. Science. 2001;294:1024-1030.
2. Bibb JA, Snyder GL, Nishi A, et al. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature. 1999;402:669-671.
3. Svenningsson P, Lindskog M, Ledent C, et al. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc Natl Acad Sci U S A. 2000;97:1856-1860.
4. Kurihara T, Lewis RM, Eisler J, Greengard P. Cloning of cDNA for DARPP-32, a dopamine- and cyclic AMP-regulated neuronal phosphoprotein. J Neurosci. 1988;8:508-517.
5. Varis A, Wolf M, Monni O, et al. Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res. 2002;62:2625-2629.
6. El-Rifai W, Smith MF Jr., Li G, et al. Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP. Cancer Res. 2002;62:4061-4064.
7. Greengard P, Allen PB, Nairn AC. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron. 1999;23:435-447.
8. Huang HB, Horiuchi A, Watanabe T, et al. Characterization of the inhibition of protein phosphatase-1 by DARPP-32 and inhibitor-2. J Biol Chem. 1999;274:7870-7878.
9. Liu F, Ma XH, Ule J, et al. Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors. Proc Natl Acad Sci U S A. 2001;98:11062-11068.
10. Hemmings HC Jr., Greengard P, Tung HY, Cohen P. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature. 1984;310: 503-505.
11. Girault JA, Hemmings HC Jr., Williams KR, Nairn AC, Greengard P. Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II. J Biol Chem. 1989;264:21748-21759.